Hospital-Acquired Infection Diagnostics Market Share Analysis of The Top Industry Players, Demand, Growth Opportunities and Country Level Segments
The growing
geriatric population, development of technologically advanced products, and
increasing demand for hospital-acquired infection (HAI)
diagnostics in
developing economies are driving the hospital-acquired infection (HAI)
diagnostics market.
It generated
a $2,657.6 million revenue in 2016, and is expected to grow at a 7.6% CAGR
during the forecast period (2017–2023). HAIs, also known as nosocomial
infections, are caught on during hospitalization at nursing homes, hospitals,
outpatient clinics, rehabilitation centers, and other clinical settings.
The
development of technologically advanced products is one of the key driving
factors for the HAI diagnostics market. Advancements in technology have
resulted in the development of products that offer low turnaround time and
reliable results. This has resulted in the development of molecular diagnostics
as a separate niche, which is attracting many companies to invest in it. For
instance, the cobas Liat PCR system with four assays was launched by Roche
Diagnostics in 2017, which can conduct a 20-minute real-time PCR nucleic acid
test for Clostridium difficile detection.
Request
to Get the Sample Pages at:
The HAI
diagnostics market is segmented by end user, product, region, test type,
infection type, and application. Based on infection type, the classifications
are hospital-acquired pneumonia, urinary tract infections (UTI), gastrointestinal
infections, surgical site infections, and bloodstream infections. The UTI
classification garnered the highest revenue of $829.0 million in 2017, and is
expected to generate a revenue of $1,337.1 million by 2023. The Centers for
Disease Control and Prevention mentioned that of all the cases of
hospital-acquired UTIs, about 75.0% are associated with a urinary catheter.
The
application segment of the HAI diagnostics market is subdivided into drug resistance
testing and disease testing. The diagnosis process has become easier and more
accurate with the inclusion of advanced technology that has led to the
development of many modern techniques. Technological advancements have resulted
in the development of mass spectrometry, nucleic acid-based technology,
isothermal microcalorimetry, flow cytometry, and near-infrared spectroscopy,
which are heavily employed in the diagnosis of infectious diseases. This is
expected to result in the faster growth of the disease testing category at a
7.9% CAGR during the forecast period.
Therefore,
the market is set to advance in the forecast period due to technological advancements,
growing geriatric population, and rising prevalence of HAIs in emerging
economies as well.
Comments
Post a Comment